Clinical Trial Update: Clinical Trial Based on the Use of Mononuclear Cells From Autologous Bone Marrow in Patients With Pseudoarthrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous bone marrow mononuclear cells for treating pseudoarthrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudoarthrosis

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Pseudoarthrosis | Phase 2 | Status: COMPLETED